The Fem Max Troche is a compounded sublingual troche designed specifically for female sexual health support. It combines active compounds that address the neurological and vascular components of female arousal and desire — targeting pathways that hormonal changes during perimenopause and menopause frequently disrupt.
Female sexual desire and arousal involve complex interplay between hormones, neurotransmitters, blood flow, and psychological factors. The Fem Max troche addresses the physiological side of this equation — supporting the biological mechanisms that drive arousal response and libido when hormonal decline has blunted them.
The sublingual delivery method allows active compounds to absorb rapidly through the tissue under the tongue, bypassing first-pass liver metabolism. This means faster onset, more efficient delivery, and a discreet format.
The Fem Max troche is recommended for women experiencing declining libido or arousal response — particularly during perimenopause and menopause. It can be used alongside HRT (estradiol and progesterone) or as a standalone protocol.
Addresses the neurological components of female arousal that hormonal decline disrupts during perimenopause and menopause.
Enhances the physiological mechanisms that drive blood flow and sensitivity — the biological foundation of arousal.
Dissolves under the tongue for faster absorption than oral tablets. Discreet and convenient.
Not a repurposed male ED medication. Compounded with female physiology and hormone profiles in mind.
The Fem Max Troche is used on an as-needed basis. Place one troche under the tongue and allow it to dissolve completely. Onset is typically faster than oral medication. Your provider determines the appropriate frequency based on your clinical evaluation.
Standard supply is 30 troches per month. Can be used alongside HRT protocols (estradiol and progesterone) or as a standalone sexual health protocol.
Discreet, fast-acting, and convenient. No pills to swallow, no injections, no complicated timing requirements.
Your Biology. Reborn.
Medical Disclaimer: The information on this page is for educational purposes and does not constitute medical advice. All BioPhoenix protocols require a provider evaluation and prescription. Individual results vary based on health history, lab values, and adherence to the prescribed protocol.
Compounding Disclosure: Compounded medications are prepared by a licensed 503A compounding pharmacy. Compounded medications are not FDA-approved but are prepared in compliance with federal and state pharmacy regulations. All compounds are sterile, third-party tested, and dispensed pursuant to a valid prescription.
Pricing Disclosure: Prices shown are medication costs. Total program pricing includes provider evaluation, clinical oversight, and shipping. See program page for complete pricing details.
BioPhoenix Inc. is a Management Services Organization (MSO). BioPhoenix does not practice medicine. All clinical decisions are made by independent licensed providers. BioPhoenix supports, optimizes, and enhances access to care — it does not diagnose, treat, cure, or prevent any disease.
BioPhoenix Inc. is a marketing and management services organization. We are not a medical practice, pharmacy, or licensed healthcare provider. All clinical services are provided by independent, licensed healthcare professionals operating through licensed physician-owned professional corporations. All medical consultations are performed exclusively by licensed medical providers. Prescriptions are issued at the sole discretion of treating physicians and are not guaranteed. Medications are dispensed by licensed compounding pharmacies. BioPhoenix services are not available to individuals under 18 years of age. These services are not a substitute for emergency care. If you are experiencing a medical emergency, call 911 immediately.BioPhoenix is not a covered entity under HIPAA. Your health information is handled pursuant to our Privacy Policy and Business Associate Agreements with our clinical partners.
